Metformin Use in Cardiac Fibrosis in PAI-1 Deficiency

Clinical trial NCT05317806 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05317806
Sponsor: Indiana Hemophilia &Thrombosis Center, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Plasminogen Activator Inhibitor-1 Deficiency Cardiac Fibrosis

Start date: 2022-10-10
Primary completion: 2027-10-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.